Annual Operating Expenses
$32.08 M
+$12.01 M+59.87%
31 December 2023
Summary:
AIM ImmunoTech annual total operating expenses is currently $32.08 million, with the most recent change of +$12.01 million (+59.87%) on 31 December 2023. During the last 3 years, it has risen by +$17.70 million (+123.15%). AIM annual operating expenses is now at all-time high.AIM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$4.52 M
+$780.00 K+20.88%
30 September 2024
Summary:
AIM ImmunoTech quarterly total operating expenses is currently $4.52 million, with the most recent change of +$780.00 thousand (+20.88%) on 30 September 2024. Over the past year, it has dropped by -$3.66 million (-44.74%). AIM quarterly operating expenses is now -67.87% below its all-time high of $14.06 million, reached on 31 December 2023.AIM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +59.9% | -44.7% |
3 y3 years | +123.2% | +18.7% |
5 y5 years | +192.2% | +48.8% |
AIM Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +123.2% | -67.9% | +45.3% |
5 y | 5 years | at high | +192.2% | -67.9% | +54.6% |
alltime | all time | at high | +646.0% | -67.9% | +477.5% |
AIM ImmunoTech Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $4.52 M(+20.9%) |
June 2024 | - | $3.74 M(-35.2%) |
Mar 2024 | - | $5.77 M(-59.0%) |
Dec 2023 | $32.08 M(+59.9%) | $14.06 M(+72.0%) |
Sept 2023 | - | $8.17 M(+48.5%) |
June 2023 | - | $5.50 M(+26.7%) |
Mar 2023 | - | $4.34 M(-22.6%) |
Dec 2022 | $20.06 M(+22.8%) | $5.61 M(-14.2%) |
Sept 2022 | - | $6.54 M(+40.5%) |
June 2022 | - | $4.66 M(+49.8%) |
Mar 2022 | - | $3.11 M(-43.9%) |
Dec 2021 | $16.34 M(+13.7%) | $5.54 M(+45.6%) |
Sept 2021 | - | $3.81 M(+9.9%) |
June 2021 | - | $3.46 M(-2.1%) |
Mar 2021 | - | $3.54 M(-27.2%) |
Dec 2020 | $14.37 M(+23.0%) | $4.86 M(+52.5%) |
Sept 2020 | - | $3.19 M(+0.2%) |
June 2020 | - | $3.18 M(+0.4%) |
Mar 2020 | - | $3.17 M(+8.4%) |
Dec 2019 | $11.69 M(+6.5%) | $2.92 M(-3.8%) |
Sept 2019 | - | $3.04 M(-0.1%) |
June 2019 | - | $3.04 M(+12.7%) |
Mar 2019 | - | $2.69 M(+2.9%) |
Dec 2018 | $10.98 M(+2.9%) | $2.62 M(-8.7%) |
Sept 2018 | - | $2.87 M(-6.7%) |
June 2018 | - | $3.07 M(+27.1%) |
Mar 2018 | - | $2.42 M(-5.1%) |
Dec 2017 | $10.67 M(-16.6%) | $2.55 M(+8.7%) |
Sept 2017 | - | $2.34 M(-14.0%) |
June 2017 | - | $2.73 M(-10.8%) |
Mar 2017 | - | $3.06 M(-20.1%) |
Dec 2016 | $12.79 M(-15.8%) | $3.82 M(+28.5%) |
Sept 2016 | - | $2.98 M(+17.2%) |
June 2016 | - | $2.54 M(-26.4%) |
Mar 2016 | - | $3.45 M(+37.8%) |
Dec 2015 | $15.19 M(-15.8%) | $2.50 M(-31.5%) |
Sept 2015 | - | $3.65 M(-17.7%) |
June 2015 | - | $4.44 M(-3.2%) |
Mar 2015 | - | $4.59 M(+7.0%) |
Dec 2014 | $18.05 M(+12.2%) | $4.29 M(+5.3%) |
Sept 2014 | - | $4.07 M(-15.7%) |
June 2014 | - | $4.83 M(-0.8%) |
Mar 2014 | - | $4.87 M(+47.8%) |
Dec 2013 | $16.08 M(-13.4%) | $3.29 M(-22.4%) |
Sept 2013 | - | $4.24 M(+2.6%) |
June 2013 | - | $4.13 M(-6.3%) |
Mar 2013 | - | $4.41 M(-41.4%) |
Dec 2012 | $18.56 M(+38.4%) | $7.54 M(+87.6%) |
Sept 2012 | - | $4.02 M(+15.6%) |
June 2012 | - | $3.47 M(-1.8%) |
Mar 2012 | - | $3.54 M(+0.9%) |
Dec 2011 | $13.41 M(-11.6%) | $3.51 M(+3.7%) |
Sept 2011 | - | $3.38 M(+9.9%) |
June 2011 | - | $3.08 M(-10.4%) |
Mar 2011 | - | $3.44 M(-17.9%) |
Dec 2010 | $15.18 M | $4.19 M(+18.1%) |
Sept 2010 | - | $3.55 M(+1.8%) |
June 2010 | - | $3.48 M(-12.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $3.96 M(+3.0%) |
Dec 2009 | $12.79 M(+4.2%) | $3.85 M(+64.7%) |
Sept 2009 | - | $2.34 M(-39.2%) |
June 2009 | - | $3.84 M(+39.2%) |
Mar 2009 | - | $2.76 M(-3.3%) |
Dec 2008 | $12.28 M(-36.8%) | $2.85 M(-12.7%) |
Sept 2008 | - | $3.27 M(+10.8%) |
June 2008 | - | $2.95 M(-7.9%) |
Mar 2008 | - | $3.20 M(-22.5%) |
Dec 2007 | $19.42 M(+5.8%) | $4.13 M(-33.8%) |
Sept 2007 | - | $6.25 M(+53.2%) |
June 2007 | - | $4.08 M(-17.8%) |
Mar 2007 | - | $4.96 M(+13.5%) |
Dec 2006 | $18.35 M(+73.0%) | $4.37 M(+15.3%) |
Sept 2006 | - | $3.79 M(-19.0%) |
June 2006 | - | $4.67 M(-15.4%) |
Mar 2006 | - | $5.52 M(+69.4%) |
Dec 2005 | $10.61 M(+6.0%) | $3.26 M(+37.5%) |
Sept 2005 | - | $2.37 M(-11.6%) |
June 2005 | - | $2.68 M(+16.8%) |
Mar 2005 | - | $2.29 M(+10.3%) |
Dec 2004 | $10.01 M(+35.1%) | $2.08 M(-8.4%) |
Sept 2004 | - | $2.27 M(+23.9%) |
June 2004 | - | $1.83 M(-51.8%) |
Mar 2004 | - | $3.81 M(+66.8%) |
Dec 2003 | $7.41 M(+6.4%) | $2.28 M(+20.7%) |
Sept 2003 | - | $1.89 M(+11.7%) |
June 2003 | - | $1.69 M(+9.9%) |
Mar 2003 | - | $1.54 M(+96.9%) |
Dec 2002 | $6.96 M(-24.3%) | $782.00 K(-60.1%) |
Sept 2002 | - | $1.96 M(-6.5%) |
June 2002 | - | $2.10 M(-1.1%) |
Mar 2002 | - | $2.12 M(+21.2%) |
Dec 2001 | $9.19 M(-10.9%) | $1.75 M(-22.6%) |
Sept 2001 | - | $2.26 M(-9.7%) |
June 2001 | - | $2.50 M(-6.4%) |
Mar 2001 | - | $2.68 M(-5.7%) |
Dec 2000 | $10.32 M(-25.1%) | $2.84 M(+11.7%) |
Sept 2000 | - | $2.54 M(+1.2%) |
June 2000 | - | $2.51 M(+6.3%) |
Mar 2000 | - | $2.36 M(-56.9%) |
Dec 1999 | $13.78 M(+74.4%) | $5.48 M(+138.1%) |
Sept 1999 | - | $2.30 M(-20.7%) |
June 1999 | - | $2.90 M(-9.4%) |
Mar 1999 | - | $3.20 M(+39.1%) |
Dec 1998 | $7.90 M(+14.5%) | $2.30 M(+15.0%) |
Sept 1998 | - | $2.00 M(+11.1%) |
June 1998 | - | $1.80 M(0.0%) |
Mar 1998 | - | $1.80 M(+5.9%) |
Dec 1997 | $6.90 M(+38.0%) | $1.70 M(+6.3%) |
Sept 1997 | - | $1.60 M(+23.1%) |
June 1997 | - | $1.30 M(-48.0%) |
Mar 1997 | - | $2.50 M(+78.6%) |
Dec 1996 | $5.00 M(+16.3%) | $1.40 M(-17.6%) |
Sept 1996 | - | $1.70 M(+54.5%) |
June 1996 | - | $1.10 M(+37.5%) |
Mar 1996 | - | $800.00 K |
Dec 1995 | $4.30 M | - |
FAQ
- What is AIM ImmunoTech annual total operating expenses?
- What is the all time high annual operating expenses for AIM ImmunoTech?
- What is AIM ImmunoTech annual operating expenses year-on-year change?
- What is AIM ImmunoTech quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly operating expenses year-on-year change?
What is AIM ImmunoTech annual total operating expenses?
The current annual operating expenses of AIM is $32.08 M
What is the all time high annual operating expenses for AIM ImmunoTech?
AIM ImmunoTech all-time high annual total operating expenses is $32.08 M
What is AIM ImmunoTech annual operating expenses year-on-year change?
Over the past year, AIM annual total operating expenses has changed by +$12.01 M (+59.87%)
What is AIM ImmunoTech quarterly total operating expenses?
The current quarterly operating expenses of AIM is $4.52 M
What is the all time high quarterly operating expenses for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly total operating expenses is $14.06 M
What is AIM ImmunoTech quarterly operating expenses year-on-year change?
Over the past year, AIM quarterly total operating expenses has changed by -$3.66 M (-44.74%)